Evidence map›Paper›PMID 39756366›Full record

ArticleInternational journal of biological macromolecules2025

Retraction notice to "Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance" [Int. J. Biol. Macromol. 222PA (2022) 1538-1550].

Hanieh Shirvani, Hanieh Jafari, Sayyed Sajjad Moravveji, Fatemeh Abbasi Faranghizadeh, Mehrdad Talebi, Jalaledin Ghanavi, Farbod Esfandi, Sajad Najafi, Masomeh Nasiri Moghadam, Poopak Farnia and 1 more

Abstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of biological macromolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Hanieh ShirvaniBiocenter Oulu and Faculity of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Hanieh JafariE-Health Barakat Company Researcher, Tehran, Iran.
Sayyed Sajjad MoravvejiE-Health Barakat Company Ceo, Tehran, Iran.
Fatemeh Abbasi FaranghizadehFaculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Mehrdad TalebiDepartment of Medical Genetics, Faculity of Medicine, Shahid Sadoughi University of Medical Science, Yazd, Iran.
Jalaledin GhanaviMycobacteriology Research Centre, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Farbod EsfandiDepartment of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Sajad NajafiDepartment of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Masomeh Nasiri MoghadamDepartment of Agronomy, Faculity of Agriculture, University of Kurdistan, Sanandaj, Iran.
Poopak FarniaMycobacteriology Research Centre, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Seyed Mohsen Aghaei ZarchDepartment of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39756366
PMCPMC11976054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.